Clinical trial
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple…
NCT00451204 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00451204 |
|---|---|
| Title | A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) |
| Official title | A Combination Trial of Copaxone Plus Estriol in RRMS |
| Acronym | Estriol-MS |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | Washington University School of Medicine University of Texas Southwestern Medical Center Ohio State University University of Medicine and Dentistry of New Jersey University of Chicago University of… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Estriol, Placebo, Copaxone |
| Enrollment | 158 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 1, 2014 |
| First posted | Mar 23, 2007 |
| Last update posted | Jun 16, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: